OLYSIO® (simeprevir)
AXERT® (almotriptan malate) Tablets
CONCERTA® (methylphenidate HCI) Extended-Release Tablets CII
DARZALEX™ (daratumumab)
DOXIL® (doxorubicin HCl liposome injection)
DURAGESIC® (fentanyl transdermal system) CII
EDURANT® (rilpivirine)
ELMIRON® (pentosan polysulfate sodium) Capsules
HALDOL® (haloperidol)
HALDOL® DECANOATE (haloperidol)
HALDOL® DECANOATE
INTELENCE® (etravirine)
INVEGA® (paliperidone)
INVEGA SUSTENNA® (paliperidone palmitate)
INVEGA SUSTENNA®
INVEGA TRINZA® (paliperidone palmitate) extended-release injectable suspension 273 mg, 410 mg, 546 mg, or 819 mg
INVEGA TRINZA®
INVOKAMET® (canagliflozin/metformin HCl) tablets
INVOKANA® (canagliflozin)
LEVAQUIN® (levofloxacin) Tablets
OLYSIO® (simeprevir)
OneTouch® Meters and Test Strips
ORTHO TRI-CYCLEN® LO (norgestimate/ethinyl estradiol)
ORTHO TRI-CYCLEN® LO
PANCREAZE® (pancrelipase) Delayed-Release Capsules
PREZCOBIX™ (darunavir 800 mg/ cobicistat 150 mg) tablets
PREZISTA® (darunavir) Tablets
PROCRIT® (epoetin alfa)
RAZADYNE® (galantamine)
RAZADYNE® ER (galantamine HBr) Extended-Release Capsules
RAZADYNE® ER
REMICADE® (infliximab)
RISPERDAL® (risperidone)
RISPERDAL CONSTA® (risperidone)
RISPERDAL CONSTA®
SIMPONI® (golimumab)
SIMPONI ARIA® (golimumab)
SIMPONI ARIA®
SPORANOX® (itraconazole)
STELARA® (ustekinumab)
SYLVANT® (siltuximab)
TOPAMAX® (topiramate) Tablets
XARELTO® (rivaroxaban)
YONDELIS® (trabectedin)
ZYTIGA® (abiraterone acetate)

Need help paying for your OLYSIO® (simeprevir) prescription?

We want to guide you to programs that may help. Here you'll find the financial assistance programs available for OLYSIO®. We have also listed most of the eligibility requirements for each, so you can narrow your focus to those that best suit your circumstances. Call the programs or visit their web sites to learn more.

OLYSIO® Support

1-855-5-OLYSIO (1-855-565-9746)

Monday-Friday, 8 AM to 8 PM ET

To view programs that are best suited for you, select your insurance status for OLYSIO® or view all assistance programs

You may be eligible for one or more of the following programs:

To view programs that are best suited for you, select your insurance status for OLYSIO® or view all assistance programs

You may be eligible for one or more of the following programs:

At the current time, patient affordability programs for the selected insurance option are not available for this product. Please check back, as programs change.

This program is affiliated with Janssen.

It's updated on a regular basis. Be sure to visit the program site for additional information.

OLYSIO® Savings Program

The OLYSIO® Savings Program may provide instant savings on your out-of-pocket medication costs for OLYSIO®. Once eligible patients qualify and activate their OLYSIO® Savings Card, patients pay only $5 per fill, with a maximum annual benefit of $50,000, or 12 months after activation, whichever comes first. Not valid for patients enrolled in Medicare, such as Medicare Part D, or Medicaid. Other restrictions apply.

You may be eligible if:

  • You have been prescribed OLYSIO®
  • You currently have commercial/private insurance that covers prescription costs for OLYSIO®
  • Additional restrictions apply

The following programs are not affiliated with Janssen.

Be sure to contact the programs directly to get details on eligibility and application requirements, and to see if they have funding available to help you.

Johnson & Johnson Patient Assistance Foundation

Johnson & Johnson Patient Assistance Foundation, Inc. (JJPAF) is committed to providing access to medicines for uninsured patients who lack the financial resources to pay for them. If you need OLYSIO® (simeprevir), and are uninsured and unable to pay for your medicine, please contact a JJPAF program specialist at 1-800-652-6227 9 AM to 6 PM ET or visit the foundation website at JJPAF.org to see if you might qualify for assistance.

State-Sponsored Programs

Some states sponsor prescription financial assistance programs, each with its own eligibility requirements.

Find out if your state has a program that can help you »

Medicare Savings Program

Many states have programs for people with limited income and resources that pay some or all of Medicare's premiums and may pay Medicare deductibles and co-insurance. Find out if your state has a program that can help you.

Medicare Part D Extra Help — Low-Income Subsidy

Medicare patients who have limited income and resources may qualify for "extra help" to pay for prescription drugs. The Low-Income Subsidy (LIS) program from Medicare provides financial assistance for patients who may otherwise be unable to afford the costs associated with their Medicare Part D plan.

Those who are eligible for LIS may:

  • Receive assistance paying their monthly premium
  • Have a reduced or no deductible
  • Have reduced or no prescription co-insurance and co-payments
  • Have no gap in coverage

Good Days from CDF®

This foundation provides financial assistance to those eligible for co-pays and travel costs associated with treatment.

This foundation may be able to help you if:

  • You have private/commercial or government insurance coverage for OLYSIO®
    AND
  • You are taking OLYSIO® to treat approved indication(s)

Patient Access Network Foundation

This foundation provides financial assistance to those eligible for their out-of-pocket medication expenses.

This foundation may be able to help you if:

  • You have private/commercial or government insurance coverage for OLYSIO®
    AND
  • You are taking OLYSIO® to treat approved indication(s)

Patient Advocate Foundation

This foundation provides financial assistance to those eligible for their out-of-pocket medication expenses.

This foundation may be able to help you if:

  • You have private/commercial or government insurance coverage for OLYSIO®
    AND
  • You are taking OLYSIO® to treat approved indication(s)
April 8, 2016
Expand
Expand

IMPORTANT SAFETY INFORMATION

What is OLYSIO®?

  • OLYSIO® (simeprevir) is a prescription medicine used with other antiviral medicines to treat chronic (lasting a long time) hepatitis C virus genotype 1 infection. OLYSIO® should not be taken alone. OLYSIO® is not for people with certain types of liver problems. It is not known if OLYSIO® is safe and effective in children under 18 years of age.

What is the most important information I should know about OLYSIO®?

OLYSIO® may cause serious side effects, including:

What should I tell my healthcare provider before taking OLYSIO®?

Before taking OLYSIO®, tell your healthcare provider if you:

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Some medicines may interact with OLYSIO®. This can cause you to have too much or not enough OLYSIO® or other medicines in your body, which may affect the way OLYSIO® or your other medicines work, or may cause side effects. Keep a list of your medicines and show it to your healthcare provider and pharmacist.

What are the possible side effects of OLYSIO®?

Important: You should not take OLYSIO® alone. OLYSIO® should be used together with other antiviral medicines to treat chronic hepatitis C virus infection. When taking OLYSIO® in combination with Peg-IFN-alfa and RBV you should also read those Medication Guides. When taking OLYSIO® in combination with sofosbuvir, you should also read its Patient Information leaflet.

Please see full Prescribing Information and Patient Information for more details.

041677-160226

IMPORTANT SAFETY INFORMATION

What is OLYSIO®?

  • OLYSIO® (simeprevir) is a prescription medicine used with other antiviral medicines to treat chronic (lasting a long time) hepatitis C virus genotype 1 infection. OLYSIO® should not be taken alone. OLYSIO® is not for people with certain types of liver problems. It is not known if OLYSIO® is safe and effective in children under 18 years of age.

What is the most important information I should know about OLYSIO®?

OLYSIO® may cause serious side effects, including:

What should I tell my healthcare provider before taking OLYSIO®?

Before taking OLYSIO®, tell your healthcare provider if you:

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Some medicines may interact with OLYSIO®. This can cause you to have too much or not enough OLYSIO® or other medicines in your body, which may affect the way OLYSIO® or your other medicines work, or may cause side effects. Keep a list of your medicines and show it to your healthcare provider and pharmacist.

What are the possible side effects of OLYSIO®?

Important: You should not take OLYSIO® alone. OLYSIO® should be used together with other antiviral medicines to treat chronic hepatitis C virus infection. When taking OLYSIO® in combination with Peg-IFN-alfa and RBV you should also read those Medication Guides. When taking OLYSIO® in combination with sofosbuvir, you should also read its Patient Information leaflet.

Please see full Prescribing Information and Patient Information for more details.

041677-160226